Depression Screening By 18 Years of Age
-
The percentage of adolescents 18 years of age who had a screening for depression using a standardized tool.
CBE ID1515
The percentage of adolescents 18 years of age who had a screening for depression using a standardized tool.
The percentage of patients 18-75 years of age with a serious mental illness and diabetes (type 1 and type 2) whose most recent HbA1c level during the measurement year is >9.0%.
Note: This measure is adapted from an existing health plan measure used in a variety of reporting programs for the general population (NQF #0059: Comprehensive Diabetes Care: Hemoglobin A1c (HbA1c) Control >9.0%). This measure is endorsed by NQF and is stewarded by NCQA.
Percentage of patients, aged 4-18 years, newly diagnosed with attention deficit hyperactivity disorder (ADHD) whose medical record contains documentation of DSM-V criteria.
The percentage of discharges for patients 18 years of age and older who had a visit to the emergency department with a primary diagnosis of mental health or alcohol or other drug dependence during the measurement year AND who had a follow-up visit with any provider with a corresponding primary diagnosis of mental health or alcohol or other drug dependence within 7- and 30-days of discharge.
Four rates are reported:
- The percentage of emergency department visits for mental health for which the patient received follow-up within 7 days of discharge.
The proportion of patients discharged from a hospital-based inpatient psychiatric setting on two or more antipsychotic medications.
The proportion of patients discharged from a hospital-based inpatient psychiatric setting with a post discharge continuing care plan created.
The proportion of patients discharged from a hospital-based inpatient psychiatric setting with a complete post discharge continuing care plan, all the components of which are transmitted to the next level of care provider upon discharge.
This measure identifies the percentage of patients taking lithium who have had at least one creatinine test after the earliest observed lithium prescription during the measurement year.
This measure identifies the percentage of patients taking lithium who have had at least one lithium level test after the earliest observed lithium prescription during the measurement year.
This measure identifies the percentage of patients taking lithium who have had at least one thyroid function test after the earliest observed lithium prescription during the measurement year.